Prostatic Neoplasms — Identification of Prostate Cancer Specific Markers in Patients Compared to Healthy Participants
Citation(s)
Identification and Characterization of Commercial RUO Antibodies for the Detection of Specific Prostate Cancer Tumoral Markers Expressed in Potential Circulating Tumoral Cells (CTCs)